US Stock MarketDetailed Quotes

ZVSAW ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM)

Watchlist
  • 0.070
  • 0.0000.00%
Trading Dec 20 16:00 ET
0Market Cap0.00P/E (TTM)

About ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) Company

ZyVersa Therapeutics Inc is a clinical stage specialty biopharmaceutical company that leverages advanced proprietary technologies to develop and commercialize first-in-class prescription drugs. The company's focus is on restoring health and improving quality of life for patients with high unmet medical needs, with emphasis on inflammatory and renal diseases.

Company Profile

SymbolZVSAW
Company NameZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM)
CEOMr. Stephen C. Glover
MarketNASDAQ
Fiscal Year Ends12-31

Company Executives

  • Name
  • Position
  • Salary
  • Stephen C. Glover
  • Chairman of the Board and Chief Executive Officer
  • --
  • Peter Wolfe
  • Chief Financial Officer
  • --
  • Nicholas A. LaBella,Jr
  • Chief Scientific Officer
  • --
  • Karen A. Cashmere
  • Chief Commercial Officer
  • --
  • Daniel J. O’Connor, J.D.
  • Director
  • --
  • Dr. Min-Chul Park, Pd.D
  • Director
  • --
  • Robert G. Finizio
  • Director
  • --
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.